1. Laboratory Diagnosis of Porphyria
- Author
-
Anna Maria Nicolli, Dario Tavazzi, Silvia Fustinoni, Andrea Trevisan, Rosa Mercadante, Stefano Marchini, Francesca Granata, Elena Di Pierro, Maria Savino, and Michele De Canio
- Subjects
0301 basic medicine ,Medicine (General) ,NGS (next-generation sequencing) ,diagnosis ,Clinical Biochemistry ,EPNET (european porphyria network) ,Review ,porphyrins ,Bioinformatics ,porphyria ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,HPLC (high-pressure liquid chromatography) ,MLPA (multiplex ligation-dependent probe amplification) ,Medicine ,PBG - Porphobilinogen ,HPLC - High pressure liquid chromatography ,business.industry ,Heme biosynthesis ,PBG (porphobilinogen) ,Diagnostic test ,medicine.disease ,ALA (5-aminolevulinic acid) ,Molecular analysis ,030104 developmental biology ,Porphyria ,030220 oncology & carcinogenesis ,business ,ALA - 5-aminolevulinic acid - Abstract
Porphyrias are a group of diseases that are clinically and genetically heterogeneous and originate mostly from inherited dysfunctions of specific enzymes involved in heme biosynthesis. Such dysfunctions result in the excessive production and excretion of the intermediates of the heme biosynthesis pathway in the blood, urine, or feces, and these intermediates are responsible for specific clinical presentations. Porphyrias continue to be underdiagnosed, although laboratory diagnosis based on the measurement of metabolites could be utilized to support clinical suspicion in all symptomatic patients. Moreover, the measurement of enzymatic activities along with a molecular analysis may confirm the diagnosis and are, therefore, crucial for identifying pre-symptomatic carriers. The present review provides an overview of the laboratory assays used most commonly for establishing the diagnosis of porphyria. This would assist the clinicians in prescribing appropriate diagnostic testing and interpreting the testing results.
- Published
- 2021
- Full Text
- View/download PDF